Cell membranes and liposomes dissociate C-reactive protein (CRP) to form a new, biologically active structural intermediate: mCRPm

FASEB Journal

Volumn 21, Issue 1, 2007, Pages 284-294

  Ji, Shang Rong ^a   Wu, Yi ^a   Zhu, Li ^a   Potempa, Lawrence A ^b   Sheng, Fen Ling ^a   Lu, Wei ^a   Zhao, Jing ^a  

^a LANZHOU UNIVERSITY   (China)

^b Immtech Pharmaceuticals Inc   (United States)

Author keywords

Cardiovascular disease; Inflammation; Protein membrane interaction

Indexed keywords

C REACTIVE PROTEIN; EPITOPE; ISOPROTEIN; LIPOSOME;

ANTIGENICITY; ARTICLE; CELL MEMBRANE; COMPLEMENT FIXATION; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; ELECTRON MICROSCOPY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN EXPRESSION; PROTEIN STRUCTURE;

ANIMALS; C-REACTIVE PROTEIN; CELL MEMBRANE; HYDROLYSIS; LIPOSOMES; MICE; MICROSCOPY, ELECTRON; SPECTROMETRY, FLUORESCENCE;

EID: 33846001313     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.06-6722com     Document Type: Article

References (44)

1. Pepys, M. B., and Hirschfield, G. M. (2003) C-reactive protein: a critical update. J. Clin. Invest. 111, 1805-1812
2. Volanakis, J. E. (2001) Human C-reactive protein: expression, structure, and function. Mol. Immunol. 38, 189-197
3. Schwedler, S. B., Filep, J. G., Galle, J., Wanner, C., and Potempa, L. A. (2006) C-reactive protein: a family of proteins to regulate cardiovascular function. Am. J. Kidney Dis. 47, 212-222
4. Verma, S., Szmitko, P. E., and Yeh, E. T. H. (2004) C-reactive protein? Structure affects function. Circulation 109, 1914-1917
5. Yeh, E. T. (2005) A new perspective on the biology of C-reactive protein. Circ. Res. 97, 609-611
6. Potempa, L. A., Siegel, J. N., Fiedel, B. A., Potempa, R. T., and Gewurz, H. (1987) Expression, detection, and assay of neoantigen (Neo-CRP) associated with a free, human C-reactive protein subunit. Mol. Immunol. 24, 531-541
7. Diehl, E. E., Haines, G. K., Radosevich, J. A., and Potempa, L. A. (2000) Immunohistochemical localization of modified C-reactive protein antigen in normal vascular tissue. Am. J. Med. Sci. 319, 79-83
8. Mold, C., Gewurz, H., and Du Clos, T. W. (1999) Regulation of complement activation by C-reactive protein. Immunopharmacology 42, 23-30
9. Szalai, A. J. (2004) C-reactive protein (CRP) and autoimmune disease: facts and conjectures. Clin. Dev. Immunol. 11, 221-226
10. Wilson, A. M., Ryan, M. C., and Boyle, A. J. (2006) The novel role of C-reactive protein in cardiovascular disease: risk marker or pathogen. Int. J. Cardiol. 106, 291-297
11. Jialal, I., Devaraj, S., and Venugopal, S. (2004) C-reactive protein: risk marker or mediator in atherothrombosis? Hypertension 44, 6-11
12. Sepulvedaa, J. L., and Mehtab, J. L. (2005) C-reactive protein and cardiovascular disease: a critical appraisal. Curr. Opin. Cardiol. 20, 407-416
13. Ridker, P. M., Rifai, N., Rose, L., Buring, J. E., and Cook, N. R. (2002) Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N. Engl. J. Med. 347, 1557-1565
14. Ji, S. R., Wu, Y., Potempa, L. A., Qiu, Q., and Zhao, J. (2006) Interactions of C-reactive protein with low density lipoproteins: implications for an active role of modified C-reactive protein in atherosclerosis. Int. J. Biochem. & Cell Biol. 38, 648-661
15. Ji, S. R., Wu, Y., Potempa, L. A., Liang, Y. H., and Zhao, J. (2006) Effect of modified C-reactive protein on complement activation. A possible complement regulatory role of modified or monomeric C-reactive protein in atherosclerotic lesions. Arterioscler. Thromb. Vasc. Biol. 26, 935-941
16. Khreiss, T., József, L., Potempa, L. A., and Filep, J. G. (2004) Conformational rearrangement in C-reactive protein is required for proinflammatory actions on human endothelial cells. Circulation 109, 2016-2022
17. Khreiss, T., Jozsef, L., Potempa, L. A., and Filep, J. G. (2005) Loss of pentameric symmetry in C-reactive protein induces interleukin-8 secretion through peroxynitrite signaling in human neutrophils. Circ. Res. 97, 690-697
18. Ying, S., Gewurz, H., Kinoshita, C. M., Potempa, L. A., and Gewurz, H. (1989) Identification and partial characterization of multiple native and neoantigenic epitopes of human C-reactive protein by using monoclonal antibodies. J. Immunol. 143, 221-228
19. Zouki, C., Haas, B., Chan, J. S. D., Potempa, L. A., and Filep, J. G. (2001) Loss of pentameric symmetry of C-reactive protein is associated with promotion of neutrophil-endothelial cell adhesion. J. Immunol. 167, 5355-5361
20. Khreiss, T., Jozsef, L., Hossain, S., Chan, J. S. D., Potempa, L. A., and Filep, J. G. (2002) Loss of pentameric symmetry of C-reactive protein is associated with delayed apoptosis of human neutrophils. J. Biol. Chem. 277, 40775-40781
21. Wu, Y., He, Y., Bai, J., Ji, S. R., Tucker, W. C., Chapman, E. R., and Sui, S. F. (2003) Visualization of synaptotagmin I oligomers assembled onto lipid monolayers. Proc. Natl. Acad. Sci. U. S. A. 100, 2082-2807
22. Wu, Y., Wang, H. W., Ji, S. R., and Sui, S. F. (2003) Two-dimensional crystallization of rabbit C-reactive protein monomeric subunits. Acta Crystallogr. D Biol. Crystallogr. 59, 922-926
23. Gershov, D., Kim, S., Brot, N., and Elkon, K. B. (2000) C-reactive protein binds to apoptotic cells, protects the cells from assembly of the terminal complement components, and sustains an antiinflammatory innate immune response: implications for systemic autoimmunity. J. Exp. Med. 192, 1353-1363
24. Volanakis, J. E., and Wirtz, K. W. A. (1979) Interaction of C-reactive protein with artificial phosphatidylcholine bilayers. Nature 281, 155-157
25. Shrive, A. K., Cheetham, M. T., Holden, D., Myles, D. A. A., Turnell, W. G., Volanakis, J. E., Pepys, M. B., Bloomer, A. C., and Greenhough, T. J. (1996) Three-dimensional structure of human C-reactive protein. Nat. Struct. Biol. 3, 346-353
26. Wang, H. W., and Sui, S. F. (2001) Dissociation and subunits rearrangement of membrane-bound human C-reactive proteins. Biochem. Bioph. Res. Co. 288, 75-79
27. Wu, Y., Ji, S. R., and Sui, S. F. (2002) Study of the spontaneous disassociation of rabbit C-reactive protein. Biochemistry-Moscow 67, 1377-1382
28. Agrawal, A., Shrive, A. K., Greenhough, T. J., and Volanakis, J. E. (2001) Topology and structure of the C1q-binding site on C-reactive protein. J. Immunol. 166, 3998-4004
29. Crowell, R. E., Du Clos, T. W., Montoya, G., Heaphy, E., and Mold, C. (1991) C-reactive protein receptors on the human monocytic cell line U-937. Evidence for additional binding to Fc gamma RI. J. Immunol. 147, 3445-3451
30. Bharadwaj, D., Stein, M. P., Volzer, M., Mold, C., and Du Clos, T. W. (1999) The major receptor for C-reactive protein on leukocytes is fcgamma receptor II. J. Exp. Med. 190, 585-590
31. Bang, R., Marnell, L., Mold, C., Stein, M. P., Clos, K. T., Chivington-Buck, C., and Clos, T. W. (2005) Analysis of binding sites in human C-reactive protein for Fc{gamma}RI, Fc{gamma}RIIA, and C1q by site-directed mutagenesis. J. Biol. Chem. 280, 25095-25102
32. Devaraj, S., Du Clos, T. W., and Jialal, I. (2005) Binding and internalization of C-reactive protein by Fcgamma receptors on human aortic endothelial cells mediates biological effects. Arterioscler. Thromb. Vasc. Biol. 25, 1359-1363
33. Pepys, M. B., Hirschfield, G. M., Tennent, G. A., Ruth Gallimore, J., Kahan, M. C., Bellotti, V., Hawkins, P. N., Myers, R. M., Smith, M. D., Polara, A., et al. (2006) Targeting C-reactive protein for the treatment of cardiovascular disease. Nature 440, 1217-1221
34. Lougheed, M., Lum, C. M., Ling, W., Suzuki, H., Kodama, T., and Steinbrecher, U. P. (1997) High affinity saturable uptake of oxidized low density lipoprotein by macrophages from mice lacking the scavenger receptor class A type I/II. J. Biol. Chem. 272, 12938-12944
35. Taskinen, S., Kovanen, P. T., Jarva, H., Meri, S., and Pentikainen, M. O. (2002) Binding of C-reactive protein to modified low-density-lipoprotein particles: identification of cholesterol as a novel ligand for C-reactive protein. Biochem. J. 367, 403-412
36. Simons, K., and Ikonen, E. (1997) Functional rafts in cell membranes. Nature 387, 569-572
37. Vigushin, D. M., Pepys, M. B., and Hawkins, P. N. (1993) Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease. J. Clin. Invest. 91, 1351-1357
38. Thompson, D., Pepys, M. B., and Wood, S. P. (1999) The physiological structure of human C-reactive protein and its complex with phosphocholine. Structure 7, 169-177
39. Schwedler, S. B., Amann, K., Wernicke, K., Krebs, A., Nauck, M., Wanner, C., Potempa, L. A., and Galle, J. (2005) Native C-reactive protein (CRP) increases, whereas modified CRP reduces atherosclerosis in ApoE-knockout-mice. Circulation 112, 1016-1023
40. Bhakdi, S., Torzewski, M., Paprokta, K., Schmitt, S., Barsoom, H., Suriyaphol, P., Han, S., Lackner, K. J., and Husmann, M. (2004) Possible protective role for C-reactive protein in atherogenesis. Complement activation by modified lipoproteins halts before detrimental terminal sequence. Circulation 109, 1870-1876
41. Tabas, I. (2005) Consequences and therapeutic implications of macrophage apoptosis in atherosclerosis: the importance of lesion stage and phagocytic efficiency. Arterioscler. Thromb. Vasc. Biol. 25, 2255-2264
42. Yasojima, K., Schwab, C., McGeer, E. G., and McGeer, P. L. (2001) Generation of C-reactive protein and complement components in atherosclerotic plaques. Am. J. Pathol. 158, 1039-1051
43. Ciubotaru, I., Potempa, L. A., and Wander, R. C. (2005) Production of modified C-reactive protein in U937-derived macrophages. Exp. Biol. Med. (Maywood) 230, 762-770
44. Tucci, A., Goldberger, G., Whitehead, A. S., Kay, R. M., Woods, D. E., and Colten, H. R. (1983) Biosynthesis and postsynthetic processing of human C-reactive protein. J. Immunol. 131, 2416-2419